PATENT CLAIM ANALYSIS

Application Number: 15891620
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "234100"]

Abstract:
The invention relates to vaccines for treating prostate inflammation and benign prostate hyperplasias (stages I and II) comprising  Lactobacillus  strains in an inactivated form and carriers and/or excipients commonly used in vaccine preparations.

Claim (Index 2):
A method of treating a patient suffering from prostate inflammation, benign prostate hyperplasia stage I, or benign prostate hyperplasia stage II, said method comprising vaccinating said patient intramuscularly with an effective dose of a suspension of a mixture of  Lactobacillus plantarum, Lactobacillus paracasei  and  Lactobacillus fermentum  in its inactivated form.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 88.0
- Lexical Diversity: 1.125
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13049344', '14911730', '10606114', '10508324', '15132286']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6381476602517266
- 35 USC 102 Novelty (BERT): 0.5182537870768036
- Combined Prediction Score: 0.6261582729342343
- Mean Citation Score: 173.795106
- Max Citation Score: 313.15186
- Similarity Product: 277.17412924685595

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test